Early Experience With Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement in the United States
- PMID: 32091552
- PMCID: PMC7042802
- DOI: 10.1001/jamainternmed.2019.6767
Early Experience With Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement in the United States
Abstract
This survey study evaluates the early post–US Food and Drug Administration approval experience with an embolic protection device used during transcatheter aortic valve replacement procedures.
Conflict of interest statement
Comment in
-
Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Replacement-Effective in Stroke Prevention?JAMA Intern Med. 2020 May 1;180(5):785-786. doi: 10.1001/jamainternmed.2019.6763. JAMA Intern Med. 2020. PMID: 32091530 No abstract available.
References
-
- Alqahtani F, Sengupta PP, Badhwar V, McCarthy P, Alkhouli M. Clinical and economic burden of acute ischemic stroke following transcatheter aortic valve replacement. Struct Heart. 2019;3(1):72-73. doi:10.1080/24748706.2018.1539281 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
